Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
株式のランク
#2010
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
株価
$6.40
時価総額
$10.19B
変化（1日）
-0.77%
変化（1年）
27.14%
国
CN
取引 Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
カテゴリー
Healthcare
Sichuan Kelun Pharmaceutical Co., Ltd. Class A（002422）の利益
Jun 2026 時点の利益 TTM: $380.26M
Sichuan Kelun Pharmaceutical Co., Ltd. Class A の最新の財務報告によると、同社の現在の利益は $380.26M です。2024 年には $587.11M の利益を上げ、これは 2023 年の利益 $505.81M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Sichuan Kelun Pharmaceutical Co., Ltd. Class A の利益の推移（2007 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $380.26M | 10.67% |
| 2025 | $343.58M | -41.48% |
| 2024 | $587.11M | 16.07% |
| 2023 | $505.81M | 68.72% |
| 2022 | $299.79M | 61.80% |
| 2021 | $185.28M | 26.74% |
| 2020 | $146.19M | -18.97% |
| 2019 | $180.42M | -6.93% |
| 2018 | $193.85M | 10.51% |
| 2017 | $175.41M | 69.99% |
| 2016 | $103.19M | -1.58% |
| 2015 | $104.84M | -43.47% |
| 2014 | $185.46M | -12.29% |
| 2013 | $211.43M | 3.94% |
| 2012 | $203.43M | 14.70% |
| 2011 | $177.35M | 51.03% |
| 2010 | $117.43M | 53.61% |
| 2009 | $76.45M | 48.40% |
| 2008 | $51.51M | 46.84% |
| 2007 | $35.08M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $5.27B | 1,287.20% |
US
|
|
| $-3.09B | -911.82% |
US
|
|
| $-4.02B | -1,156.18% |
AU
|
|
| $3.01B | 690.44% |
BE
|
|
| $1.95B | 412.98% |
NL
|
